Immuneering Corp’s recent filing unveils that its 10% Owner Cormorant Asset Management, LP unloaded Company’s shares for reported $1.16 million on Apr 01 ’24. In the deal valued at $2.90 per share,400,000 shares were sold. As a result of this transaction, Cormorant Asset Management, LP now holds 2,895,273 shares worth roughly $6.69 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Schall Thomas J. bought 2,900 shares, generating $7,385 in total proceeds. Upon buying the shares at $2.55, the Director now owns 2,900 shares.
Before that, Feinberg Peter bought 25,000 shares. Immuneering Corp shares valued at $63,713 were divested by the Director at a price of $2.55 per share. As a result of the transaction, Feinberg Peter now holds 111,766 shares, worth roughly $0.26 million.
Needham reiterated its Immuneering Corp [IMRX] rating to a Buy in a research note published on March 15, 2024; the price target was $15. A number of analysts have revised their coverage, including TD Cowen’s analysts, who decreased its forecast for the stock in mid March from “an Outperform” to “a Market perform”. Jefferies also remained covering IMRX and has decreased its forecast on March 15, 2024 with a “Hold” recommendation from previously “Buy” rating. Needham started covering the stock on December 01, 2023. It rated IMRX as “a Buy”.
Price Performance Review of IMRX
On Tuesday, Immuneering Corp [NASDAQ:IMRX] saw its stock jump 15.50% to $2.31. Over the last five days, the stock has lost -3.35%. Immuneering Corp shares have fallen nearly -68.57% since the year began. Nevertheless, the stocks have fallen -61.50% over the past one year. While a 52-week high of $8.89 was reached on 03/04/24, a 52-week low of $1.00 was recorded on 08/16/24. SMA at 50 days reached $1.77, while 200 days put it at $2.86.
Levels Of Support And Resistance For IMRX Stock
The 24-hour chart illustrates a support level at 2.14, which if violated will result in even more drops to 1.96. On the upside, there is a resistance level at 2.50. A further resistance level may holdings at 2.68. The Relative Strength Index (RSI) on the 14-day chart is 53.00, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.20, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 64.95%. Stochastics %K at 16.53% indicates the stock is a buying.
How much short interest is there in Immuneering Corp?
A steep rise in short interest was recorded in Immuneering Corp stocks on 2024-09-30, growing by 0.11 million shares to a total of 1.63 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-30 was 1.52 million shares. There was a rise of 6.95%, which implies that there is a positive sentiment for the stock.
